LCTX
(NYSEAMERICAN)Lineage Cell Therapeutics, Inc.
---- (--)
Loading... - Market loading
Lineage Cell Therapeutics (LCTX) Stock Price & Financial Analysis
Lineage Cell Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$1.66 - $1.76
52-Week High$2.09
52-Week Low$0.37
Open$1.71
Volume786.95K
Average Volume (3M)1.20M
Market Cap384.47M
Shares Outstanding228.85M
Price to Sales (P/S)35.55
Price to Book (P/B)17.44
EV/EBITDA-7.59
Revenue (TTM)10.82M
Net Income (TTM)-67.66M
Free Cash Flow (TTM)-20.63M
EPS (TTM)$-0.30
Profit Margin-625.53%
Operating Margin-188.06%
Return on Equity (ROE)-306.97%
Debt to Equity0.12
50-Day MA$1.69
200-Day MA$1.33
52-Week Change141.76%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateDec 15, 2003
Day's Range$1.66 - $1.76
52-Week High$2.09
52-Week Low$0.37
Open$1.71
Volume786.95K
Average Volume (3M)1.20M
Market Cap384.47M
Shares Outstanding228.85M
Price to Sales (P/S)35.55
Price to Book (P/B)17.44
EV/EBITDA-7.59
Revenue (TTM)10.82M
Net Income (TTM)-67.66M
Free Cash Flow (TTM)-20.63M
EPS (TTM)$-0.30
Profit Margin-625.53%
Operating Margin-188.06%
Return on Equity (ROE)-306.97%
Debt to Equity0.12
50-Day MA$1.69
200-Day MA$1.33
52-Week Change141.76%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateDec 15, 2003
Latest News
Recent news and articles about LCTX